176 related articles for article (PubMed ID: 23564716)
1. Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism.
Xu L; Liu H; Zhang H; Wang RX; Song J; Zhou RX
Anat Rec (Hoboken); 2013 Jun; 296(6):914-20. PubMed ID: 23564716
[TBL] [Abstract][Full Text] [Related]
2. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells.
Carbajo-Pescador S; Martín-Renedo J; García-Palomo A; Tuñón MJ; Mauriz JL; González-Gallego J
J Pineal Res; 2009 Nov; 47(4):330-8. PubMed ID: 19817970
[TBL] [Abstract][Full Text] [Related]
3. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
[TBL] [Abstract][Full Text] [Related]
4. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.
Winczyk K; Fuss-Chmielewska J; Lawnicka H; Pawlikowski M; Karasek M
Neuro Endocrinol Lett; 2009; 30(5):657-62. PubMed ID: 20035258
[TBL] [Abstract][Full Text] [Related]
5. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
[TBL] [Abstract][Full Text] [Related]
6. Role of CD4+ CD25+ regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth in vivo and in vitro.
Liu H; Xu L; Wei JE; Xie MR; Wang SE; Zhou RX
Anat Rec (Hoboken); 2011 May; 294(5):781-8. PubMed ID: 21416626
[TBL] [Abstract][Full Text] [Related]
7. [Anti-gastric cancer effect of melatonin and Bcl-2, Bax, p21 and p53 expression changes].
Xu L; Jin QD; Gong X; Liu H; Zhou RX
Sheng Li Xue Bao; 2014 Dec; 66(6):723-9. PubMed ID: 25516522
[TBL] [Abstract][Full Text] [Related]
8. Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection.
Kaneko Y; Hayashi T; Yu S; Tajiri N; Bae EC; Solomita MA; Chheda SH; Weinbren NL; Parolini O; Borlongan CV
J Pineal Res; 2011 Apr; 50(3):272-80. PubMed ID: 21269327
[TBL] [Abstract][Full Text] [Related]
9. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL
BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288
[TBL] [Abstract][Full Text] [Related]
10. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
[TBL] [Abstract][Full Text] [Related]
11. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance.
Tam CW; Chan KW; Liu VW; Pang B; Yao KM; Shiu SY
J Pineal Res; 2008 Nov; 45(4):403-12. PubMed ID: 18637986
[TBL] [Abstract][Full Text] [Related]
12. [MT1 melatonin receptors and their role in the oncostatic action of melatonin].
Danielczyk K; Dziegiel P
Postepy Hig Med Dosw (Online); 2009 Sep; 63():425-34. PubMed ID: 19837985
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle.
Domínguez-López S; Mahar I; Bambico FR; Labonté B; Ochoa-Sánchez R; Leyton M; Gobbi G
J Psychopharmacol; 2012 Jun; 26(6):830-44. PubMed ID: 21730015
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of melatonin treatment in primary culture of canine mammary tumors.
Lopes JR; Maschio LB; Jardim-Perassi BV; Moschetta MG; Ferreira LC; Martins GR; Gelaleti GB; De Campos Zuccari DA
Oncol Rep; 2015 Jan; 33(1):311-9. PubMed ID: 25384569
[TBL] [Abstract][Full Text] [Related]
15. Cetrorelix, a gonadotropin-releasing hormone antagonist, induces the expression of melatonin receptor 1a in the gonadotropin-releasing hormone neuronal cell line GT1-7.
Ishii H; Sato S; Yin C; Sakuma Y; Kato M
Neuroendocrinology; 2009; 90(3):251-9. PubMed ID: 19641296
[TBL] [Abstract][Full Text] [Related]
16. Melatonin inhibits cell growth and migration, but promotes apoptosis in gastric cancer cell line, SGC7901.
Zhang S; Qi Y; Zhang H; He W; Zhou Q; Gui S; Wang Y
Biotech Histochem; 2013 Aug; 88(6):281-9. PubMed ID: 23477595
[TBL] [Abstract][Full Text] [Related]
17. Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2).
Fic M; Podhorska-Okolow M; Dziegiel P; Gebarowska E; Wysocka T; Drag-Zalesinska M; Zabel M
In Vivo; 2007; 21(3):513-8. PubMed ID: 17591362
[TBL] [Abstract][Full Text] [Related]
18. Chronopharmacology of melatonin in mice to maximize the antitumor effect and minimize the rhythm disturbance effect.
Akagi T; Ushinohama K; Ikesue S; Yukawa E; Higuchi S; Hamase K; Zaitsu K; Ohdo S
J Pharmacol Exp Ther; 2004 Jan; 308(1):378-84. PubMed ID: 14563786
[TBL] [Abstract][Full Text] [Related]
19. Melatonin induces calcium mobilization and influences cell proliferation independently of MT1/MT2 receptor activation in rat pancreatic stellate cells.
Santofimia-Castaño P; Garcia-Sanchez L; Ruy DC; Sanchez-Correa B; Fernandez-Bermejo M; Tarazona R; Salido GM; Gonzalez A
Cell Biol Toxicol; 2015 Apr; 31(2):95-110. PubMed ID: 25764371
[TBL] [Abstract][Full Text] [Related]
20. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms.
Lissoni P
Pathol Biol (Paris); 2007; 55(3-4):201-4. PubMed ID: 17446010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
